Rhythm Pharmaceuticals
RYTM
RYTM
101 hedge funds and large institutions have $1.47B invested in Rhythm Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 22
18.38% more ownership
Funds ownership: 91.19% → 109.57% (+18%)
12% more funds holding
Funds holding: 90 → 101 (+11)
Holders
101
Holding in Top 10
6
Calls
$35.4M
Puts
$14.5M
Top Buyers
| 1 | +$70.5M | |
| 2 | +$57.8M | |
| 3 | +$47.5M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$46.8M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$46.4M |
Top Sellers
| 1 | -$7.38M | |
| 2 | -$5.37M | |
| 3 | -$4.91M | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$4.14M |
| 5 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$3.77M |